454 results on '"Citera,Gustavo"'
Search Results
52. Frecuencia de infección por SARS-CoV-2 en asistentes a un congreso médico en la Ciudad Autónoma de Buenos Aires
53. Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
54. Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population
55. Clinical and immunogenetic characterization in psoriatic arthritis patients
56. Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina
57. Effects of cigarette smoking on early arthritis: a cross-sectional study—data from the Argentine Consortium for Early Arthritis (CONAART)
58. Fatigue assessment and its impact in the quality of life of patients with ankylosing spondylitis
59. Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors
60. Acceso al tratamiento con drogas modificadoras de la enfermedad biológicas o sintéticas dirigidas en pacientes con artritis reumatoidea
61. Consenso de inmunizaciones en adultos con enfermedades reumáticas inflamatorias crónicas autoinmunes
62. Spondyloarthritis
63. Plain language summary for the manuscript: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial
64. Enhanced Publication Content for the manuscript: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial
65. Speciality training in rheumatology: Promotion, repetition and dropout rates in the city of Buenos Aires
66. Epidemiology of Spondyloarthritis in Argentina
67. Respuesta immune humoral asociada a las vacunas contra SARS-CoV-2 en pacientes con artritis reumatoidea: datos del registro SAR-CoVAC
68. Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria
69. The −308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients
70. Rheumatologist's role regarding vaccination for COVID 19 in people with rheumatic diseases
71. El papel del reumatólogo con respecto a la vacunación contra COVID 19 en personas con enfermedades reumáticas
72. Disease activity and subcutaneous nodules are associated to severe periodontitis in patients with rheumatoid arthritis
73. SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis
74. Beyond Rheumatoid Arthritis Evaluation: What are We Missing?
75. Adherence to treatment in patients with ankylosing spondylitis
76. A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis
77. Survival, efficacy and safety of Golimumab in patients with Rheumatoid Arthritis and Spondyloarthritis: data from an Argentine cohort
78. Peripheral arthritis and higher disease activity lead to more functional impairment in axial spondyloarthritis: Longitudinal analysis from ESPAXIA
79. Additional file 1 of Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
80. RETRACTED ARTICLE: Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire
81. Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
82. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
83. Validation of the ReXSPA index (Reductive X-ray Score for Psoriatic Arthritis) in patients with Psoriatic arthritis of the RAPSODIA cohort
84. Association between Rheumatoid Arthritis and other autoimmune diseases
85. 'Treat to Persist', a deepening of 'Treat to Target'
86. Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or anti-TNF agents: a systematic review and network
87. Adherencia al tratamiento con tofacitinib en pacientes con artritis reumatoide en la práctica clínica diaria
88. Cambios en la función endotelial vascular de pacientes con artritis reumatoidea en tratamiento
89. Rheumatoid Arthritis in Latin Americans Enriched for Amerindian Ancestry is Associated With Loci in Chromosomes 1, 12, and 13, and the HLA Class II Region
90. Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab for Rheumatoid Arthritis: Findings of a Phase Iiib, Multinational, Prospective, Randomized Study
91. Head to Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial.: 2449
92. General characteristics of an early arthritis cohort in Argentina
93. Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry
94. Validation of the ReXSPA (Reductive X-ray Score for Psoriatic Arthritis) index in patients with Psoriatic Arthritis of the RAPSODIA cohort
95. “Treat to Persist”, a deepening of the “Treat to Target”
96. Association between Rheumatoid Arthritis and other autoimmune diseases
97. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire
98. The Prevalence of Rheumatoid Arthritis in Argentina: A Capture-Recapture Study in a City of Buenos Aires Province
99. Factors Associated With Disability in Patients With Rheumatoid Arthritis
100. Clinical significance of anti-Ro antibodies in rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.